Show simple item record

dc.contributor.authorKibirige, D
dc.contributor.authorSekitoleko, I
dc.contributor.authorBalungi, P
dc.contributor.authorKyosiimire-Lugemwa, J
dc.contributor.authorLumu, W
dc.contributor.authorJones, AG
dc.contributor.authorHattersley, AT
dc.contributor.authorSmeeth, L
dc.contributor.authorNyirenda, MJ
dc.date.accessioned2022-08-23T15:03:47Z
dc.date.issued2022-05-23
dc.date.updated2022-07-31T21:27:06Z
dc.description.abstractAIMS: This study aimed to investigate the frequency of islet autoantibody positivity in adult patients with recently diagnosed diabetes in Uganda and its associated characteristics. METHODS: Autoantibodies to glutamic acid decarboxylase-65 (GADA), zinc transporter 8 (ZnT8-A), and tyrosine phosphatase (IA-2A) were measured in 534 adult patients with recently diagnosed diabetes. Islet autoantibody positivity was defined based on diagnostic thresholds derived from a local adult population without diabetes. The socio-demographic, clinical, and metabolic characteristics of islet autoantibody-positive and negative participants were then compared. The differences in these characteristics were analysed using the x2 test for categorical data and the Kruskal Wallis test for continuous data. Multivariate analysis was performed to identify predictors of islet autoantibody positivity. RESULTS: Thirty four (6.4%) participants were positive for ≥1 islet autoantibody. GADA, IA-2A and ZnT8-A positivity was detected in 17 (3.2%), 10 (1.9%), and 7 (1.3%) participants, respectively. Compared with those negative for islet autoantibodies, participants positive for islet autoantibodies were more likely to live in a rural area (n = 18, 52.9% Vs n = 127, 25.5%, p = 0.005), to be initiated on insulin therapy (n = 19, 55.9% Vs n = 134, 26.8%, p<0.001), to have a lower median waist circumference (90 [80-99] cm Vs 96 [87-104.8], p = 0.04), waist circumference: height ratio (0.55 [0.50-0.63] vs 0.59 [0.53-0.65], p = 0.03), and fasting C-peptide concentration (0.9 [0.6-1.8] Vs 1.4 [0.8-2.1] ng/ml, p = 0.01). On multivariate analysis, living in a rural area (odds ratio or OR 3.62, 95%CI 1.68-7.80, p = 0.001) and being initiated on insulin therapy (OR 3.61, 95% CI 1.67-7.83, p = 0.001) were associated with islet autoantibody positivity. CONCLUSION: The prevalence of islet autoantibody positivity was relatively low, suggesting that pancreatic autoimmunity is a rare cause of new-onset diabetes in this adult Ugandan population. Living in a rural area and being initiated on insulin therapy were independently associated with islet autoantibody positivity in this study population.en_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipUK Department for International Development (DFID)en_GB
dc.identifier.citationVol. 17(5), article e0268783en_GB
dc.identifier.doihttps://doi.org/10.1371/journal.pone.0268783
dc.identifier.grantnumberGHR-17/63/131en_GB
dc.identifier.grantnumberMC_UP_1204/16en_GB
dc.identifier.urihttp://hdl.handle.net/10871/130500
dc.identifierORCID: 0000-0002-0883-7599 (Jones, Angus G)
dc.identifierORCID: 0000-0001-5620-473X (Hattersley, Andrew T)
dc.language.isoenen_GB
dc.publisherPublic Library of Science (PLoS)en_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/35604955en_GB
dc.rights© 2022 Kibirige et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_GB
dc.subjectislet autoantibody positivityen_GB
dc.subjectadult-onset diabetesen_GB
dc.subjectnew-onset diabetesen_GB
dc.subjectUgandaen_GB
dc.subjectsub-Saharan Africaen_GB
dc.titleIslet autoantibody positivity in an adult population with recently diagnosed diabetes in Ugandaen_GB
dc.typeArticleen_GB
dc.date.available2022-08-23T15:03:47Z
dc.identifier.issn1932-6203
exeter.place-of-publicationUnited States
dc.descriptionThis is the final version. Available on open access from Public Library of Science via the DOI in this recorden_GB
dc.descriptionData Availability: All relevant data are within the paper and its Supporting Information files.en_GB
dc.identifier.eissn1932-6203
dc.identifier.journalPLoS Oneen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2022-05-07
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2022-05-23
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-08-01T10:58:14Z
refterms.versionFCDVoR
refterms.dateFOA2022-08-23T15:03:53Z
refterms.panelAen_GB
refterms.dateFirstOnline2022-05-23


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2022 Kibirige et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Except where otherwise noted, this item's licence is described as © 2022 Kibirige et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.